Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CICLOPIROX OLAMINE Cause Therapy partial responder? 6 Reports in FDA Database

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Therapy partial responder have been filed in association with CICLOPIROX OLAMINE (Ciclopirox Olamine). This represents 2.1% of all adverse event reports for CICLOPIROX OLAMINE.

6
Reports of Therapy partial responder with CICLOPIROX OLAMINE
2.1%
of all CICLOPIROX OLAMINE reports
0
Deaths
6
Hospitalizations

How Dangerous Is Therapy partial responder From CICLOPIROX OLAMINE?

Of the 6 reports, 6 (100.0%) required hospitalization.

Is Therapy partial responder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CICLOPIROX OLAMINE. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does CICLOPIROX OLAMINE Cause?

Drug ineffective (118) Device dislocation (70) Device malfunction (68) Product use in unapproved indication (38) Condition aggravated (16) Rash (16) Type 2 diabetes mellitus (15) Myocardial infarction (14) Angioplasty (12) Acute kidney injury (11)

What Other Drugs Cause Therapy partial responder?

CYCLOPHOSPHAMIDE (1,397) RITUXIMAB (1,219) DEXAMETHASONE (1,199) PREDNISONE (1,176) PEMBROLIZUMAB (1,125) CARBOPLATIN (1,096) DOXORUBICIN (834) METHOTREXATE (775) VINCRISTINE (707) ETOPOSIDE (670)

Which CICLOPIROX OLAMINE Alternatives Have Lower Therapy partial responder Risk?

CICLOPIROX OLAMINE vs CICLOSPORIN CICLOPIROX OLAMINE vs CIDOFOVIR CICLOPIROX OLAMINE vs CILASTATIN CICLOPIROX OLAMINE vs CILASTATIN\IMIPENEM CICLOPIROX OLAMINE vs CILAZAPRIL ANHYDROUS

Related Pages

CICLOPIROX OLAMINE Full Profile All Therapy partial responder Reports All Drugs Causing Therapy partial responder CICLOPIROX OLAMINE Demographics